Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.2% |
| 2 | Technology | 16.96% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Communication Services | 11.19% |
| 5 | Consumer Staples | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
GFL Environmental
GFL
$15.1B
| $4.03M | ﹤0.01% |
+138,600
| New | +$3.39M |
|
1727
Fabrinet
FN
$20.4B
| $4.01M | ﹤0.01% |
51,700
-51,400
| -50% | -$3.5M |
|
1728
Acushnet Holdings
GOLF
$5.26B
| $4M | ﹤0.01% |
98,600
-39,900
| -29% | -$1.49M |
|
1729
Apyx Medical
APYX
$128M
| $3.99M | ﹤0.01% |
554,395
-5,400
| -1% | -$35.8K |
|
1730
Saga Communications
SGA
$62.1M
| $3.99M | ﹤0.01% |
166,207
-1,874
| -1% | -$39.1K |
|
1731
Ampco-Pittsburgh
AP
$194M
| $3.99M | ﹤0.01% |
728,201
+123,277
| +20% | +$569K |
|
1732
Townsquare Media
TSQ
$104M
| $3.95M | ﹤0.01% |
593,506
+22,554
| +4% | +$131K |
|
|
IVAC
1733
DELISTED
Intevac Inc
IVAC
| $3.94M | ﹤0.01% |
546,677
+33,463
| +7% | +$201K |
|
|
LITB
1734
LightInTheBox
LITB
$55.3M
| $3.93M | ﹤0.01% |
258,103
+41,616
| +19% | +$629K |
|
|
SCTL
1735
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $3.93M | ﹤0.01% |
1,379,785
-84,103
| -6% | -$189K |
|
|
CARM
1736
DELISTED
Carisma Therapeutics
CARM
| $3.93M | ﹤0.01% |
145,551
+44,705
| +44% | +$1.13M |
|
|
HONE
1737
DELISTED
HarborOne Bancorp
HONE
| $3.93M | ﹤0.01% |
361,727
-181,108
| -33% | -$1.78M |
|
1738
FedEx
FDX
$79.2B
| $3.92M | ﹤0.01% |
+15,100
| New | +$4.18M |
|
|
BBU
1739
DELISTED
Brookfield Business Partners
BBU
| $3.9M | ﹤0.01% |
161,253
+119,654
| +288% | +$2.65M |
|
1740
Gentherm
THRM
$1.35B
| $3.89M | ﹤0.01% |
59,700
-21,564
| -27% | -$1.16M |
|
|
ROIC
1741
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.89M | ﹤0.01% |
290,700
-418,900
| -59% | -$5.13M |
|
|
ADMS
1742
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.89M | ﹤0.01% |
898,584
+74,580
| +9% | +$319K |
|
|
CFMS
1743
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.88M | ﹤0.01% |
235,319
+26,755
| +13% | +$462K |
|
1744
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.3B
| $3.87M | ﹤0.01% |
169,762
+91,364
| +117% | +$2.02M |
|
|
AERI
1745
DELISTED
Aerie Pharmaceuticals
AERI
| $3.87M | ﹤0.01% |
286,510
-32,590
| -10% | -$394K |
|
|
AKRO
1746
DELISTED
Akero Therapeutics
AKRO
| $3.87M | ﹤0.01% |
149,900
+113,700
| +314% | +$3.16M |
|
|
CSLT
1747
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.87M | ﹤0.01% |
2,973,200
+455,996
| +18% | +$513K |
|
1748
Mativ Holdings
MATV
$674M
| $3.86M | ﹤0.01% |
96,098
-86,600
| -47% | -$3.11M |
|
|
DX
1749
Dynex Capital
DX
$3.24B
| $3.86M | ﹤0.01% |
216,945
+169,545
| +358% | +$2.9M |
|
1750
United-Guardian
UG
$32.8M
| $3.85M | ﹤0.01% |
268,123
-200
| -0.1% | -$2.92K |
|
Similar funds
Jim Simons's Q4 2020 Portfolio in Review
As of Q4 2020, Jim Simons held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in NVIDIA worth $524M.
- Jim Simons's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Jim Simons added most to Amazon in Q4 2020, an estimated $306M increase.
- Jim Simons's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Jim Simons fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Jim Simons's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Jim Simons opened 565 new positions and closed 555 in Q4 2020.
- Jim Simons's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.